IMRN - （Immuron Limited）

Highlights:

WILMINGTON, DE / ACCESSWIRE / October 19, 2022 / Transparency Market Research Inc. - A recent demand analysis of alcoholic hepatitis therapeutics market indicated that there is a large unmet need for effective treatments for severe alcoholic hepatitis (AH). High morbidity and short-term mortality of alcohol-associated liver disease worldwide has spurred R&D into its pathogenesis. The alcoholic hepatitis therapeutics market is forecast to advance at a CAGR of approximately 6% during 2020 - 2030. Increasing incidence of alcohol-associated liver disease is propelling the sales of alcoholic hepatitis therapeutics market. Stridently the number of small- and medium-scale firms in the market has grown significantly. These market participants are testing the efficacy of novel therapeutics based on modification of gut microbiota, found emerging trends of alcoholic hepatitis therapeutics market. Get Exclusive PDF Sample Copy of Alcoholic Hepatitis Therapeutics Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=12209 Key Findings of Alcoholic Hepatitis Therapeutics Market Study Continuing Research on New Targets to Enrich Drug Pipeline: Top players are exploring drugs that are capable of being used for new therapeutic targets in a growing number of clinical studies.

Immuron Limited (NASDAQ: IMRN ) signed a strategic investment and option agreement with Ateria Health Limited for an upfront cash investment of £1.48 million. The company has also announced a strategic investment of approximately £1.5 million (A$2.6 million) to acquire an initial 17.5% of Ateria Health. Potential adjustment to share percentage for Immuron dependent on Ateria''s performance during its CY2023. Ateria Health Ltd is a U.K.-based health … Full story available on Benzinga.com

Australia''s Immuron (IMRN) said it is acquiring 17.5% stake in U.K

The following slide deck was published by Immuron Limited in conjunction with their 2022 Q4 earnings call.

The U.S. Naval Medical Research Center (NMRC) has received FDA feedback related to Immuron Limited''s (NASDAQ: IMRN ) Investigational New Drug (IND) application for a new oral therapeutic targeting Campylobacter and ETEC. The agency has specified that the IND does not contain sufficient information to assess the risk to subjects in the proposed clinical studies. The IND has been placed … Full story available on Benzinga.com

The U.S. Food and Drug Administration placed a clinical hold on the start of trials of an oral antibacterial drug noting insufficient information in the investigational new drug …

Immuron (IMRN) announces North America, Travelan sales were up by 494%, reaching AU $0.6M in FY22, compared to AU $0.1M in FY21

Highlights: North American FY22 Travelan sales increased by +494% to $0.6M Global sales increased by 431% to $0.9M Australian FY22 sales increased by 318% to $0.3M MELBOURNE, Australia, July 11, 2022 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company that has developed two commercially

Gainers United Maritime Corporation (NASDAQ: USEA ) jumped 180.4% to $8.02. The company’s stock jumped 190% on Wednesday after completing its spin-off from Seanergy Maritime Holdings Corp. American Rebel Holdings, Inc. (NASDAQ: AREB ) gained 85% to $1.4150. American Rebel Holdings agreed to acquire Utah-based Champion Safe Company and its ancillary companies, in a transaction valued at $9.9 million. Grove Collaborative Holdings, Inc. (NYSE: GROV ) shares jumped 66.3% to $6.65 amid news the company''s products will now be available in Kohl''s (NYSE: KSS ), Midwest-based Meijer and also Giant Eagle. Kiromic BioPharma, Inc. (NASDAQ: KRBP ) surged 41% to $0.54. Kiromic BioPharma completed the construction of its expanded current good manufacturing practice manufacturing facility in Houston. Faraday Future Intelligent Electric Inc. (NASDAQ: FFIE ) gained 39% to $6.31. Allena Pharmaceuticals, Inc. (NASDAQ: ALNA ) jumped 30.6% to $0.2311 after declining over 8% on Wednesday. Allena Pharmaceuticals recently announced rescheduling of special meeting to approve reverse stock split.

The U.S. Naval Medical Research Center (NMRC) has received FDA feedback related to Immuron Limited''s (NASDAQ: IMRN ) Investigational New Drug (IND) application for a new oral therapeutic targeting Campylobacter and ETEC. The agency has specified that the IND does not contain sufficient information to assess the risk to subjects in the proposed clinical studies. The IND has been placed … Full story available on Benzinga.com

The U.S. Food and Drug Administration placed a clinical hold on the start of trials of an oral antibacterial drug noting insufficient information in the investigational new drug …

Immuron (IMRN) announces North America, Travelan sales were up by 494%, reaching AU $0.6M in FY22, compared to AU $0.1M in FY21

Highlights: North American FY22 Travelan sales increased by +494% to $0.6M Global sales increased by 431% to $0.9M Australian FY22 sales increased by 318% to $0.3M MELBOURNE, Australia, July 11, 2022 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company that has developed two commercially

Gainers United Maritime Corporation (NASDAQ: USEA ) jumped 180.4% to $8.02. The company’s stock jumped 190% on Wednesday after completing its spin-off from Seanergy Maritime Holdings Corp. American Rebel Holdings, Inc. (NASDAQ: AREB ) gained 85% to $1.4150. American Rebel Holdings agreed to acquire Utah-based Champion Safe Company and its ancillary companies, in a transaction valued at $9.9 million. Grove Collaborative Holdings, Inc. (NYSE: GROV ) shares jumped 66.3% to $6.65 amid news the company''s products will now be available in Kohl''s (NYSE: KSS ), Midwest-based Meijer and also Giant Eagle. Kiromic BioPharma, Inc. (NASDAQ: KRBP ) surged 41% to $0.54. Kiromic BioPharma completed the construction of its expanded current good manufacturing practice manufacturing facility in Houston. Faraday Future Intelligent Electric Inc. (NASDAQ: FFIE ) gained 39% to $6.31. Allena Pharmaceuticals, Inc. (NASDAQ: ALNA ) jumped 30.6% to $0.2311 after declining over 8% on Wednesday. Allena Pharmaceuticals recently announced rescheduling of special meeting to approve reverse stock split.